Cargando…
Regulated Mesenchymal Stem Cells Mediated Colon Cancer Therapy Assessed by Reporter Gene Based Optical Imaging
Colorectal cancer is the most common cancer in both men and women and the second most common cause of cancer-related deaths. Suicide gene-based therapy with suicide gene-transduced mesenchymal stem cells (MSCs) is a promising therapeutic strategy. A tetracycline-controlled Tet-On inducible system us...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5979455/ https://www.ncbi.nlm.nih.gov/pubmed/29584688 http://dx.doi.org/10.3390/ijms19041002 |
_version_ | 1783327700765638656 |
---|---|
author | Kalimuthu, Senthilkumar Zhu, Liya Oh, Ji Min Lee, Ho Won Gangadaran, Prakash Rajendran, Ramya Lakshmi Baek, Se Hwan Jeon, Yong Hyun Jeong, Shin Young Lee, Sang-Woo Lee, Jaetae Ahn, Byeong-Cheol |
author_facet | Kalimuthu, Senthilkumar Zhu, Liya Oh, Ji Min Lee, Ho Won Gangadaran, Prakash Rajendran, Ramya Lakshmi Baek, Se Hwan Jeon, Yong Hyun Jeong, Shin Young Lee, Sang-Woo Lee, Jaetae Ahn, Byeong-Cheol |
author_sort | Kalimuthu, Senthilkumar |
collection | PubMed |
description | Colorectal cancer is the most common cancer in both men and women and the second most common cause of cancer-related deaths. Suicide gene-based therapy with suicide gene-transduced mesenchymal stem cells (MSCs) is a promising therapeutic strategy. A tetracycline-controlled Tet-On inducible system used to regulate gene expression may be a useful tool for gene-based therapies. The aim of this study was to develop therapeutic MSCs with a suicide gene that is induced by an artificial stimulus, to validate therapeutic gene expression, and to monitor the MSC therapy for colon cancer using optical molecular imaging. For our study, we designed the Tet-On system using a retroviral vector and developed a response plasmid RetroX-TRE (tetracycline response element) expressing a mutant form of herpes simplex virus thymidine kinase (HSV1-sr39TK) with dual reporters (eGFP-Fluc2). Bone marrow-derived MSCs were transduced using a RetroX-Tet3G (Clontech, CA, USA) regulatory plasmid and RetroX-TRE-HSV1-sr39TK-eGFP-IRES-Fluc2, for a system with a Tet-On (MSC-Tet-TK/Fluc2 or MSC-Tet-TK) or without a Tet-On (MSC-TK/Fluc2 or MSC-TK) function. Suicide gene engineered MSCs were co-cultured with colon cancer cells (CT26/Rluc) in the presence of the prodrug ganciclovir (GCV) after stimulation with or without doxycycline (DOX). Treatment efficiency was monitored by assessing Rluc (CT26/Rluc) and Fluc (MSC-Tet-TK and MSC-TK) activity using optical imaging. The bystander effect of therapeutic MSCs was confirmed in CT26/Rluc cells after GCV treatment. Rluc activity in CT26/Rluc cells decreased significantly with GCV treatment of DOX(+) cells (p < 0.05 and 0.01) whereas no significant changes were observed in DOX(−) cells. In addition, Fluc activity in also decreased significantly with DOX(+) MSC-Tet-TK cells, but no signal was observed in DOX(−) cells. In addition, an MSC-TK bystander effect was also confirmed. We assessed therapy with this system in a colon cancer xenograft model (CT26/Rluc). We successfully transduced cells and developed a Tet-On system with the suicide gene HSV1-sr39TK. Our results confirmed the therapeutic efficiency of a suicide gene with the Tet-On system for colon cancer. In addition, our results provide an innovative therapeutic approach using the Tet-On system to eradicate tumors by administration of MSC-Tet-TK cells with DOX and GCV. |
format | Online Article Text |
id | pubmed-5979455 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-59794552018-06-10 Regulated Mesenchymal Stem Cells Mediated Colon Cancer Therapy Assessed by Reporter Gene Based Optical Imaging Kalimuthu, Senthilkumar Zhu, Liya Oh, Ji Min Lee, Ho Won Gangadaran, Prakash Rajendran, Ramya Lakshmi Baek, Se Hwan Jeon, Yong Hyun Jeong, Shin Young Lee, Sang-Woo Lee, Jaetae Ahn, Byeong-Cheol Int J Mol Sci Article Colorectal cancer is the most common cancer in both men and women and the second most common cause of cancer-related deaths. Suicide gene-based therapy with suicide gene-transduced mesenchymal stem cells (MSCs) is a promising therapeutic strategy. A tetracycline-controlled Tet-On inducible system used to regulate gene expression may be a useful tool for gene-based therapies. The aim of this study was to develop therapeutic MSCs with a suicide gene that is induced by an artificial stimulus, to validate therapeutic gene expression, and to monitor the MSC therapy for colon cancer using optical molecular imaging. For our study, we designed the Tet-On system using a retroviral vector and developed a response plasmid RetroX-TRE (tetracycline response element) expressing a mutant form of herpes simplex virus thymidine kinase (HSV1-sr39TK) with dual reporters (eGFP-Fluc2). Bone marrow-derived MSCs were transduced using a RetroX-Tet3G (Clontech, CA, USA) regulatory plasmid and RetroX-TRE-HSV1-sr39TK-eGFP-IRES-Fluc2, for a system with a Tet-On (MSC-Tet-TK/Fluc2 or MSC-Tet-TK) or without a Tet-On (MSC-TK/Fluc2 or MSC-TK) function. Suicide gene engineered MSCs were co-cultured with colon cancer cells (CT26/Rluc) in the presence of the prodrug ganciclovir (GCV) after stimulation with or without doxycycline (DOX). Treatment efficiency was monitored by assessing Rluc (CT26/Rluc) and Fluc (MSC-Tet-TK and MSC-TK) activity using optical imaging. The bystander effect of therapeutic MSCs was confirmed in CT26/Rluc cells after GCV treatment. Rluc activity in CT26/Rluc cells decreased significantly with GCV treatment of DOX(+) cells (p < 0.05 and 0.01) whereas no significant changes were observed in DOX(−) cells. In addition, Fluc activity in also decreased significantly with DOX(+) MSC-Tet-TK cells, but no signal was observed in DOX(−) cells. In addition, an MSC-TK bystander effect was also confirmed. We assessed therapy with this system in a colon cancer xenograft model (CT26/Rluc). We successfully transduced cells and developed a Tet-On system with the suicide gene HSV1-sr39TK. Our results confirmed the therapeutic efficiency of a suicide gene with the Tet-On system for colon cancer. In addition, our results provide an innovative therapeutic approach using the Tet-On system to eradicate tumors by administration of MSC-Tet-TK cells with DOX and GCV. MDPI 2018-03-27 /pmc/articles/PMC5979455/ /pubmed/29584688 http://dx.doi.org/10.3390/ijms19041002 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Kalimuthu, Senthilkumar Zhu, Liya Oh, Ji Min Lee, Ho Won Gangadaran, Prakash Rajendran, Ramya Lakshmi Baek, Se Hwan Jeon, Yong Hyun Jeong, Shin Young Lee, Sang-Woo Lee, Jaetae Ahn, Byeong-Cheol Regulated Mesenchymal Stem Cells Mediated Colon Cancer Therapy Assessed by Reporter Gene Based Optical Imaging |
title | Regulated Mesenchymal Stem Cells Mediated Colon Cancer Therapy Assessed by Reporter Gene Based Optical Imaging |
title_full | Regulated Mesenchymal Stem Cells Mediated Colon Cancer Therapy Assessed by Reporter Gene Based Optical Imaging |
title_fullStr | Regulated Mesenchymal Stem Cells Mediated Colon Cancer Therapy Assessed by Reporter Gene Based Optical Imaging |
title_full_unstemmed | Regulated Mesenchymal Stem Cells Mediated Colon Cancer Therapy Assessed by Reporter Gene Based Optical Imaging |
title_short | Regulated Mesenchymal Stem Cells Mediated Colon Cancer Therapy Assessed by Reporter Gene Based Optical Imaging |
title_sort | regulated mesenchymal stem cells mediated colon cancer therapy assessed by reporter gene based optical imaging |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5979455/ https://www.ncbi.nlm.nih.gov/pubmed/29584688 http://dx.doi.org/10.3390/ijms19041002 |
work_keys_str_mv | AT kalimuthusenthilkumar regulatedmesenchymalstemcellsmediatedcoloncancertherapyassessedbyreportergenebasedopticalimaging AT zhuliya regulatedmesenchymalstemcellsmediatedcoloncancertherapyassessedbyreportergenebasedopticalimaging AT ohjimin regulatedmesenchymalstemcellsmediatedcoloncancertherapyassessedbyreportergenebasedopticalimaging AT leehowon regulatedmesenchymalstemcellsmediatedcoloncancertherapyassessedbyreportergenebasedopticalimaging AT gangadaranprakash regulatedmesenchymalstemcellsmediatedcoloncancertherapyassessedbyreportergenebasedopticalimaging AT rajendranramyalakshmi regulatedmesenchymalstemcellsmediatedcoloncancertherapyassessedbyreportergenebasedopticalimaging AT baeksehwan regulatedmesenchymalstemcellsmediatedcoloncancertherapyassessedbyreportergenebasedopticalimaging AT jeonyonghyun regulatedmesenchymalstemcellsmediatedcoloncancertherapyassessedbyreportergenebasedopticalimaging AT jeongshinyoung regulatedmesenchymalstemcellsmediatedcoloncancertherapyassessedbyreportergenebasedopticalimaging AT leesangwoo regulatedmesenchymalstemcellsmediatedcoloncancertherapyassessedbyreportergenebasedopticalimaging AT leejaetae regulatedmesenchymalstemcellsmediatedcoloncancertherapyassessedbyreportergenebasedopticalimaging AT ahnbyeongcheol regulatedmesenchymalstemcellsmediatedcoloncancertherapyassessedbyreportergenebasedopticalimaging |